NCT06787742

Brief Summary

The present study aimed to evaluate and compare the clinical and radiographic outcomes of full pulpotomy in mandibular molar teeth with symptomatic irreversible pulpitis according to: A. Number of tooth surfaces defects:

  • Class I cavity defect.
  • Class II cavity defect. B. Using two types of pulpotomy dressing materials:
  • MTA+ (Cerkamed, Stalowa, Poland).
  • Well-Root PT (Vericom, Gangwon-Do, Korea). And., To correlate this outcome to the quantification of two biomolecules:
  • Tumor necrosis factor-alpha (TNF-⍺).
  • Matrix metalloproteinases-9 (MMP-9). Based on the results of the present study, it was concluded that:
  • Full pulpotomy using calcium silicate cements (CSCs) is considered a conservative, economical, and simple treatment option with a favorable prognosis for teeth with symptomatic irreversible pulpitis.
  • Class I and class II cavity defects do not adversely affect pulpotomy prognosis taking into consideration good aseptic condition, magnification, and proper seal of filling materials.
  • Although MTA+ and Well-Root PT yielded similar outcomes for pulpotomy in terms of success rates. Well-root PT is easier to handle compared to MTA+ and doesn't have a discoloration effect which is considered one of the drawbacks associated with MTA+.
  • Neither the preoperative pain nor the intraoperative bleeding time within 10 minutes influenced the pulpotomy outcome.
  • The concentration of TNF-α and MMP-9 biomarkers directly impact the outcome of pulpotomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 21, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 16, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 22, 2025

Completed
Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

January 16, 2025

Last Update Submit

June 2, 2025

Conditions

Keywords

BiomarkersCalcium silicate cementsFull pulpotomyIrreversible pulpitisMature teeth

Outcome Measures

Primary Outcomes (2)

  • success/failure

    Treatment was considered successful (healed) according to Zanini et al. (2016) based on the following criteria: (Clinically) absence of signs and symptoms of pulpal pathosis, no history of spontaneous pain or discomfort on chewing, no tenderness to percussion/palpation, no soft tissue swelling, fistula, or abnormal mobility. (Radiographically) absence of periapical rarefaction (normal width of periodontal ligament space and normal appearance of the lamina dura), internal or external resorption, and absence of root canal calcification

    Patients were scheduled for follow-up appointments (one week, 3, 6, and 12 months)

  • Pain assessment

    Pre-treatment, the patients were instructed on how to fill out a visual analog scale VAS to determine their pain score. Postoperative pain was recorded by the patient every 24 hours in the evening for 7 days. The VAS included scores from 0 to 10, which were further categorized as no pain (0), mild (1-3), moderate (4-6), severe (7-9), or severe intolerable (10).

    every 24 hours in the evening for 7 days

Study Arms (2)

A. Number of tooth surfaces defects: • Class I cavity defect. • Class II cavity defect.

ACTIVE COMPARATOR

The selected patients were divided into two groups according to the number of tooth surfaces defects (n=30) (30 with class I and 30 with class II cavity defects)

Procedure: full pulpotomy

pulpotomy dressing materials: • MTA+ (Cerkamed, Poland). • Well-Root (Vericom, Korea).

ACTIVE COMPARATOR

Each group was randomly further subdivided using Microsoft Excel into two subgroups according to the dressing materials, without informing the patients which type of material was used (n=15).

Procedure: full pulpotomy

Interventions

access to dental pulp chamber under aseptic condition, collect blood sample using a micropipette for ELIZA test, stop bleeding using sodium hypochlorite 2.5%, pulpotomy dressing material over pulp stump and final restoration with resign modified glass ionomer and composite resign

Also known as: collecting pulpal blood samples, Hemostasis, pulpotomy dressing materials, final restoration
A. Number of tooth surfaces defects: • Class I cavity defect. • Class II cavity defect.pulpotomy dressing materials: • MTA+ (Cerkamed, Poland). • Well-Root (Vericom, Korea).

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Mandibular molar teeth with signs and symptoms of symptomatic irreversible pulpitis without radiographic evidence of apical periodontitis.
  • Age range of 21-45 years old.
  • Males or females.
  • No disabilities.
  • Class I and/or class II cavity defects.
  • Teeth reveal positive response to cold tests.

You may not qualify if:

  • Presence of open apices.
  • Non-restorable teeth.
  • Teeth in which the pulpal bleeding time is more than 10 minutes.
  • Presence of large carious lesions approaching the root.
  • Presence of calcification or resorption.
  • Periodontally affected teeth.
  • Patients who are taking antibiotics within one week before treatment.
  • Patients consumed taking analgesics within 24 hours before treatment.
  • Systemically compromised patients.
  • Pregnant females.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Suez Canal University

Ismailia, Egypt

Location

MeSH Terms

Interventions

Hemostasis

Intervention Hierarchy (Ancestors)

Blood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Dalia Mukhtar Fayyad, Professor of endodontics

    Suez Canal University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
did not inform the patients which type of material was used, All laboratory procedures were performed by a single, experienced individual specializing in biochemical assays, without informing the biochemist of any outcome data of pulpotomy
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A comparative, randomized, prospective clinical study was utilized for the investigation of the outcome of pulpotomy in the treatment of adult permanent mandibular molar teeth with symptomatic irreversible pulpitis in class I and class II cavity defects using two types of hydraulic calcium silicate cement (MTA+) and (Well-root PT)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2025

First Posted

January 22, 2025

Study Start

September 21, 2022

Primary Completion

October 1, 2023

Study Completion

May 1, 2024

Last Updated

June 5, 2025

Record last verified: 2025-06

Locations